Olympus Enters Global Immunoassay Market.Tokyo, Japan, July 25, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Olympus will enter the European European emanating from or pertaining to Europe. European bat lyssavirus see lyssavirus. European beech tree fagussylvaticus. European blastomycosis see cryptococcosis. immunoassay Immunoassay An assay that quantifies antigen or antibody by immunochemical means. The antigen can be a relatively simple substance such as a drug, or a complex one such as a protein or a virus. market in July 2006. Plans call for moving a move into the US, Japanese and Asian markets once all regulatory requirements Regulatory requirements are part of the process of drug discovery and drug development. Regulatory requirements describe what is necessary for a new drug to be approved for marketing in any particular country. are satisfied. The proven technologies and internal knowledge base associated with the company's highly successful Olympus AU-clinical chemistry systems serve as a strong foundation for the Olympus AU3000i Immunoassay System and its dedicated reagents. These competencies will also support future business expansion into the clinical application of molecular diagnostic examination, which the company regards as one of the next-generation medical services. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion